Loading data
CRGONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 9.78 m USD | 8.29 m USD | 8.48 m USD | 7.86 m USD | 4.6 m USD |
| Gross profit | 19.68 m USD | 15.5 m USD | 11.8 m USD | 11.23 m USD | 6.52 m USD |
| Research and development expense | 11.94 m USD | 10.28 m USD | 11.51 m USD | 10.22 m USD | 7.82 m USD |
| Operating profit | -19.16 m USD | -22.95 m USD | -77.8 m USD | -24.27 m USD | -16.35 m USD |
| Interest expense | 268 k USD | 178 k USD | 387 k USD | 454 k USD | 156 k USD |
| Profit before tax | -17.37 m USD | -21.88 m USD | -65.56 m USD | -24.53 m USD | -16.35 m USD |
| Income tax expense | 146 k USD | 612 k USD | -85 k USD | 169 k USD | 4 k USD |
| Net income (reported basis) | -17.52 m USD | -22.49 m USD | -65.47 m USD | -24.7 m USD | -16.36 m USD |
| Basic earnings per share | -0.35 USD/share | -0.46 USD/share | -1.47 USD/share | -4.25 USD/share | -3.94 USD/share |
| Diluted earnings per share | -0.35 USD/share | -0.46 USD/share | -1.47 USD/share | -4.25 USD/share | -3.94 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.